Last updated: 30 June 2020 at 4:15pm EST

John K Bell Net Worth




The estimated Net Worth of John K Bell is at least $59.9 mil dollars as of 13 September 2019. John Bell owns over 35,000 units of DelMar Pharmaceuticals stock worth over $59,899 and over the last 11 years John sold DMPI stock worth over $0.

John Bell DMPI stock SEC Form 4 insiders trading

John has made over 11 trades of the DelMar Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently John bought 35,000 units of DMPI stock worth $23,800 on 13 September 2019.

The largest trade John's ever made was buying 50,000 units of DelMar Pharmaceuticals stock on 16 July 2015 worth over $30,000. On average, John trades about 5,605 units every 58 days since 2013. As of 13 September 2019 John still owns at least 44,701 units of DelMar Pharmaceuticals stock.

You can see the complete history of John Bell stock trades at the bottom of the page.



What's John Bell's mailing address?

John's mailing address filed with the SEC is 12707 HIGH BLUFF DR., SUITE 200, SAN DIEGO, CA, 92130.

Insiders trading at DelMar Pharmaceuticals

Over the last 11 years, insiders at DelMar Pharmaceuticals have traded over $104,000 worth of DelMar Pharmaceuticals stock and bought 663,835 units worth $651,854 . The most active insiders traders include John K Bell, Robert Hoffman, eJeffrey Bacha. On average, DelMar Pharmaceuticals executives and independent directors trade stock every 46 days with the average trade being worth of $20,766. The most recent stock trade was executed by John K Bell on 13 September 2019, trading 35,000 units of DMPI stock currently worth $23,800.



What does DelMar Pharmaceuticals do?

DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.



What does DelMar Pharmaceuticals's logo look like?

DelMar Pharmaceuticals, Inc. logo

Complete history of John Bell stock trades at DelMar Pharmaceuticals

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
13 Sep 2019 John K Bell
Diretor
Comprar 35,000 $0.68 $23,800
13 Sep 2019
44,701
15 Nov 2017 John K Bell
Diretor
Comprar 20,000 $0.81 $16,200
15 Nov 2017
95,019
26 Jun 2017 John K Bell
Diretor
Comprar 4,167 $3.60 $15,001
26 Jun 2017
49,455
6 Jun 2017 John K Bell
Diretor
Comprar 10,000 $2.12 $21,200
6 Jun 2017
45,288
16 Jul 2015 John K Bell
Diretor
Comprar 50,000 $0.60 $30,000
16 Jul 2015
137,000
21 Nov 2014 John K Bell
Diretor
Comprar 8,000 $0.95 $7,600
21 Nov 2014
87,000
8 Sep 2014 John K Bell
Diretor
Comprar 7,000 $0.71 $4,970
8 Sep 2014
79,000
4 Sep 2014 John K Bell
Diretor
Comprar 8,000 $0.78 $6,240
4 Sep 2014
72,000
22 Apr 2014 John K Bell
Diretor
Comprar 20,000 $1.25 $25,000
22 Apr 2014
64,000
18 Mar 2014 John K Bell
Diretor
Comprar 25,000 $1.30 $32,500
18 Mar 2014
44,000
11 Feb 2014 John K Bell
Diretor
Comprar 9,000 $0.83 $7,470
11 Feb 2014
19,000


DelMar Pharmaceuticals executives and stock owners

DelMar Pharmaceuticals executives and other stock owners filed with the SEC include: